US 12,108,964 B2
Minimally invasive tissue treatment device
Nikolai Aljuri, Hillsborough, CA (US); and Rodney C. Perkins, Woodside, CA (US)
Assigned to AquaBeam, LLC, Hillsborough, CA (US)
Filed by AquaBeam, LLC, Hillsborough, CA (US)
Filed on Oct. 20, 2022, as Appl. No. 18/048,296.
Application 18/048,296 is a division of application No. 16/392,984, filed on Apr. 24, 2019, granted, now 11,478,269.
Application 13/790,218 is a division of application No. 12/700,568, filed on Feb. 4, 2010, granted, now 9,232,959, issued on Jan. 12, 2016.
Application 16/392,984 is a continuation of application No. 14/956,199, filed on Dec. 1, 2015, granted, now 10,321,931, issued on Jun. 18, 2019.
Application 14/956,199 is a continuation of application No. 13/790,218, filed on Mar. 8, 2013, granted, now 9,232,960, issued on Jan. 12, 2016.
Application 12/700,568 is a continuation in part of application No. 12/399,585, filed on Mar. 6, 2009, granted, now 8,814,921, issued on Aug. 26, 2014.
Application 12/700,568 is a continuation in part of application No. 11/968,445, filed on Jan. 2, 2008, granted, now 7,882,841, issued on Feb. 8, 2011.
Claims priority of provisional application 61/097,497, filed on Sep. 16, 2008.
Claims priority of provisional application 61/034,412, filed on Mar. 6, 2008.
Claims priority of provisional application 60/883,097, filed on Jan. 2, 2007.
Prior Publication US 2023/0063051 A1, Mar. 2, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 18/14 (2006.01); A61B 17/3203 (2006.01); A61B 18/04 (2006.01); A61B 18/18 (2006.01); A61B 18/20 (2006.01); A61B 18/24 (2006.01); A61F 9/007 (2006.01); A61B 17/00 (2006.01); A61B 17/22 (2006.01); A61B 18/00 (2006.01)
CPC A61B 17/3203 (2013.01) [A61B 17/32037 (2013.01); A61B 18/04 (2013.01); A61B 18/14 (2013.01); A61B 18/1485 (2013.01); A61B 18/18 (2013.01); A61B 18/201 (2013.01); A61B 18/24 (2013.01); A61F 9/007 (2013.01); A61F 9/00736 (2013.01); A61B 2017/00274 (2013.01); A61B 2017/22079 (2013.01); A61B 2018/00196 (2013.01); A61B 2018/00285 (2013.01); A61B 2018/00547 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00583 (2013.01); A61B 2018/00946 (2013.01); A61B 2018/00952 (2013.01); A61B 2018/046 (2013.01); A61B 2018/1472 (2013.01); A61B 2018/1497 (2013.01); A61B 2018/1861 (2013.01); A61B 2218/002 (2013.01); A61B 2218/007 (2013.01)] 13 Claims
OG exemplary drawing
 
1. A tissue treatment device comprising:
a shaft having a proximal end and a distal end; and
an energy source positioned in an energy delivery region on the shaft configured to deliver an energy radially outwardly;
wherein the energy source is adapted to be translated and rotated relative to the shaft to selectively direct the energy from the energy source to treat different regions of a tissue and wherein the tissue comprises a prostate tissue and the energy source is adapted to be placed in a urethra of a patient to treat the prostate tissue, wherein the energy source comprises an electrode and the electrode comprises a laterally projecting electrode configured to engage against tissue and deliver radio frequency energy to ablate the tissue;
wherein the shaft has a width in a range from 1 mm to 10 mm and a length in a range from 15 cm to 25 cm.